Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota.
Lu Y, Fan C, Li P, Lu Y, Chang X, Qi K. · 2016
Read Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota. by Lu Y, Fan C, Li P, Lu Y, Chang X, Qi K. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5124860.txt.
Introduction
Yuanyuan Lu, Chaonan Fan, Ping Li, Yanfei Lu, Xuelian Chang, and Kemin Qi tested gut-derived acids against obesity in mice, reporting in Scientific Reports in 2016. Short chain fatty acids are made when gut microbes ferment fiber, and they may explain part of fiber's protective effect. The team fed the acids directly to mice on a high-fat diet.
Adding acetate, propionate, butyrate, or a mix of them strongly curbed weight gain. The acids shifted two receptor proteins in fat and gut tissue and reshaped the gut microbe mix toward a leaner profile, with fewer Firmicutes and more Bacteroidetes. Downstream, fat tissue burned more fat, made more heat-producing beige fat, and showed less inflammation. The results outline several routes by which these acids keep weight down.
Catalog record
| CREATOR | Lu Y, Fan C, Li P, Lu Y, Chang X, Qi K. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota By Yuanyuan Lu, Chaonan Fan, Ping Li, Yanfei Lu, Xuelian Chang, Kemin Qi Published in: Scientific Reports DOI: 10.1038/srep37589 ABSTRACT Elucidating the mechanisms by which short chain fatty acids (SCFA) reduce body weight may assist in the development of an effective weight control strategy. Dietary supplementation of acetate, propionate, butyrate or their admixture was shown to significantly inhibit the body weight gain induced by high-fat diet feeding. Supplementation of SCFAs caused significant changes in the expressions of G-protein coupled receptor 43 (GPR43) and GPR41 characterized by increases in the adipose tissue and reductions in the colon. Additionally, they influenced the bacterial community structure in feces, with a reduction in the proportion of Firmicutes and an increase in the proportion of Bacteroidetes. The effects of dietary SCFAs on the GPR expression and gut microbiota composition may further result in body weight reduction by enhancing triglyceride hydrolysis and FFA oxidation in the adipose tissue, promoting beige adipogenesis and mitochondrial biogenesis, and inhibiting chronic inflammation. The prevalence of obesity has risen substantially worldwide in both children and adults during the past several decades. Obesity and its associated complications, especially non-communicable chronic diseases, impose a double burden in health and costs12. Thus, improved strategies for obesity prevention and control are urgently needed. Epidemiological and experimental studies have demonstrated that a generous intake of dietary fiber reduces the risk for developing many chronic diseases, such as cardiovascular diseases, diabetes, certain gastrointestinal disorders, and obesity3456. Feeding rodents a high level of dietary fiber protects against the high-fat-diet-induced increases in body weight and fat mass. Moreover, a higher intake of dietary fiber can inhibit appetite and decrease body weight in humans78. Emerging evidence has shown that these effects may be partly mediated by the short chain fatty acids (SCFAs) produced via fermentation of indigestible dietary carbohydrates (predominantly resistant starch and dietary fiber) by the intestinal microbiota36. However, large amounts of dietary fibers are generally not well tolerated as they are associated with gastrointestinal side effects. Thus, SCFAs have been administered in clinical trials, and the results showed that SCFAs have a positive effect on the management of ulcerative colitis, Crohn’s disease, diarrhea and obesity910. Targeting the mechanisms by which SCFAs reduce body weight may provide a more effective approach to weight control. The major SCFAs produced by bacterial fermentation are acetate, propionate and butyrate, with an approximate molar ratio of 60:20:20, respectively, in the colon and stool11. Acetate and propionate are predominantly produced by bacterial species belonging to the Bacteroidetes phylum, whereas butyrate is primarily produced by the Firmicutes phylum12. SCFAs have been shown to mediate a variety of biological activities by targeting multiple organs and tissue sites. Numerous physiological and clinical studies have demonstrated that SCFAs are also a significant source of calories and have trophic effects on both the small and large bowel. Meanwhile, SCFAs may play beneficial roles in appetite regulation and lipid and glucose metabolism by epigenetically regulating related genes1314. SCFAs also act as signal transduction molecules and bind and activate orphan G-protein-coupled receptors, such as GPR43 and GPR41, which are also known as free fatty acid receptor 2 and 3 (FFAR2 and FFAR3), respectively. GPR43 and GPR41 are both widely expressed in the small intestine and colon, as well as tissues and organs beyond the gut1516. However, there is some debate regarding the role of these receptors in the regulation of energy balance in vivo. Studies have shown that genetically modified mice deficient in GPR43 are obese on a normal diet, whereas mice overexpressing GPR43 specifically in adipose tissue are protected against diet-induced obesity17. Inconsistently, high-fat diet (HFD)-fed GPR43-deficient mice were shown to have lower body fat mass and increased lean body mass accompanied by improved insulin sensitivity and increased energy expenditure compared to those of the normal diet-fed mice18. Thus, the protective or causative effects of GPR43 in obesity need to be clarified16. After Bäckhed and his coworkers found that gut microbiota, acting as an environmental factor, regulate fat storage19, a considerable body of studies has shown alterations in the composition of the intestinal microbiota, primarily consisting of changes in the relative abundance of the phyla Firmicutes in obesity2021, which further leads to changes in SCFA production. The fecal SCFA concentration was shown to be increased in genetically obese (ob/ob) mice and obese humans2223, whereas it was decreased in high-fat diet-induced obese (DIO) mice17. Furthermore, germ-free mice with very low gut SCFA levels were protected from diet-induced obesity19. Recently, application of exogenous acetate, propionate or butyrate has been confirmed to prevent weight gain in DIO mice and overweight humans2425. Therefore, the interactions between gut microbiota, SCFAs and their receptors, and host energy metabolism are shown to be complex by the contradictory reports in obesity. In this study, using a high-fat DIO mouse model, we determined the effects of exogenous SCFA application on body weight gain and associated changes in the GPR expressions, gut microbiota and fat oxidation. RESULTS SCFAs inhibit body weight gain in DIO mice As shown in Fig. 1, mice administered the HFD gained weight steadily over time and showed an increase in body weight that was 56.12% higher than that of the control diet group after 16 weeks of feeding (P < 0.05). Dietary supplementation of acetate, propionate, butyrate or their admixture significantly suppressed the HFD-induced weight gain, with acetate having the greatest effects at 72.31% (P < 0.05) (Fig. 1A). Two weeks after the feeding intervention, both food and energy intake were increased in the HFD-fed mice (P < 0.05), and thereafter, energy intake remained higher (P < 0.05) with no differences in food intake at both 8 and 12 weeks compared to that of the control lean mice (Fig. 1B and C). Dietary supplementation of acetate, propionate, butyrate or their admixture did not change the intakes of both food and energy at 8 and 12 weeks after the feeding intervention (P > 0.05) (Fig. 1B and C). SCFAs affect biochemical parameters and fecal SCFA excretion in DIO mice The effects of dietary SCFA supplementation on biochemical parameters are shown in Table 1. Plasma concentrations of glucose, triglycerides, cholesterol, insulin, IL-1β, IL-6 and MCP-1 were increased, and free fatty acids were decreased in the HFD-fed mice compared to those of the lean control mice (P < 0.05). Dietary supplementation of acetate, propionate, butyrate or their admixture generally attenuated the increases in triglycerides, cholesterol, IL-1β, IL-6 or MCP-1 (P < 0.05) promoted by the HFD with no effects on plasma glucose and insulin. Fecal propionate or butyrate concentration was increased in the HFD-P- and HFD-B-fed mice, respectively, compared to that of the HFD-fed mice (P < 0.05), whereas no changes in the levels of SCFAs were observed in the HFD-A-fed mice (P > 0.05), suggesting that dietary acetate was more efficiently absorbed by the intestine. SCFAs affect the GPR expression in DIO mice The mRNA levels of GPR43 were significantly lower in the adipose tissue and higher in the colon of the HFD-fed mice compared with those of the control lean mice (P < 0.05) (Fig. 2A and F). Dietary supplementation of acetate, propionate, butyrate or their admixture to the HFD